Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. | Nephron ...

The company based in Lexington County received its inspection report back from federal regulators. Here's what it showed.

This alliance provides Nephron Research leverage to expand its industry-leading brand into new markets and services and deepen its existing reach with global institutional clients. NEW YORK, Oct. 1, ...

Sharps Technology Inc. STSS shares are trading higher Thursday after the company signed a $30 million purchase order from Nephron Pharmaceuticals. Sharps said the purchase order represents the first ...

Sharps Technology Inc., a publicly traded medical device company, has plans to acquire the first fully dedicated specialized polymer syringe manufacturing plant in North America, and has been ...